Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-17

Clinical Trial Update: Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated Lactobacillus reuteri as an adjunct in managing Helicobacter pylori infection in dyspeptic patients; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Zagazig University | Conditions: Helicobacter Pylori Infection | NA | Status: COMPLETED | Results posted: 2015-08-17